Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype-Reference-Cited by-同舟云学术

Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype

Published:2020-01 Issue: Volume:292 Page:42-51
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Ramos Rafel^ORCID,Masana Luís^ORCID,Comas-Cufí Marc,García-Gil Maria^ORCID,Martí-Lluch Ruth,Ponjoan Anna,Plana Núria,Alves-Cabratosa Lia,Marrugat Jaume^ORCID,Elosua Roberto^ORCID,Dégano Irene R.,Gomez-Marcos Mauel A.,Zamora Alberto^ORCID

Funder

Ministry of Science and Innovation

Carlos III Health Institute

European Union

ERDF

Red de Investigación Cardiovascular

CIBERCV

Generalitat de Catalunya

Agència de Qualitat i Avaluació Sanitàries de Catalunya

Pla estratègic de recerca i innovació en Salut

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Reducing the burden of disease and death from familial hypercholesterolemia: a call to action;Knowles;Am. Heart J.,2014

2. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

3. Statins in familial hypercholesterolemia: consequences for coronary artery disease and all-cause mortality;Besseling;J. Am. Coll. Cardiol.,2016

4. The Agenda for Familial Hypercholesterolemia

5. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis;European Heart Journal;2024-07-08

2. Estándares de la Sociedad Española de Arteriosclerosis 2024 para el control global del riesgo vascular;Clínica e Investigación en Arteriosclerosis;2024-05

3. SEA 2024 Standards for Global Control of Vascular Risk;Clínica e Investigación en Arteriosclerosis (English Edition);2024-05

4. Recent advances in the management and implementation of care for familial hypercholesterolaemia;Pharmacological Research;2023-08

5. Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia;BMC Medicine;2023-07-27